BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28619679)

  • 1. Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1.
    Gigante A; Gómez-SanJuan A; Delang L; Li C; Bueno O; Gamo AM; Priego EM; Camarasa MJ; Jochmans D; Leyssen P; Decroly E; Coutard B; Querat G; Neyts J; Pérez-Pérez MJ
    Antiviral Res; 2017 Aug; 144():216-222. PubMed ID: 28619679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection.
    Delang L; Li C; Tas A; Quérat G; Albulescu IC; De Burghgraeve T; Guerrero NA; Gigante A; Piorkowski G; Decroly E; Jochmans D; Canard B; Snijder EJ; Pérez-Pérez MJ; van Hemert MJ; Coutard B; Leyssen P; Neyts J
    Sci Rep; 2016 Aug; 6():31819. PubMed ID: 27545976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme.
    Feibelman KM; Fuller BP; Li L; LaBarbera DV; Geiss BJ
    Antiviral Res; 2018 Jun; 154():124-131. PubMed ID: 29680670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones as novel inhibitors of Chikungunya virus replication.
    Gigante A; Canela MD; Delang L; Priego EM; Camarasa MJ; Querat G; Neyts J; Leyssen P; Pérez-Pérez MJ
    J Med Chem; 2014 May; 57(10):4000-8. PubMed ID: 24800626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-ones.
    Gómez-SanJuan A; Gamo AM; Delang L; Pérez-Sánchez A; Amrun SN; Abdelnabi R; Jacobs S; Priego EM; Camarasa MJ; Jochmans D; Leyssen P; Ng LFP; Querat G; Neyts J; Pérez-Pérez MJ
    ACS Infect Dis; 2018 Apr; 4(4):605-619. PubMed ID: 29406692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery.
    Abdelnabi R; Kovacikova K; Moesslacher J; Donckers K; Battisti V; Leyssen P; Langer T; Puerstinger G; Quérat G; Li C; Decroly E; Tas A; Marchand A; Chaltin P; Coutard B; van Hemert M; Neyts J; Delang L
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6'-β-Fluoro-Homoaristeromycin and 6'-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1.
    Kovacikova K; Morren BM; Tas A; Albulescu IC; van Rijswijk R; Jarhad DB; Shin YS; Jang MH; Kim G; Lee HW; Jeong LS; Snijder EJ; van Hemert MJ
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
    Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Use of Chikungunya Virus Replication Templates Utilizing Mammalian and Mosquito RNA Polymerase I-Mediated Transcription.
    Utt A; Rausalu K; Jakobson M; Männik A; Alphey L; Fragkoudis R; Merits A
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31217251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay.
    Ferreira-Ramos AS; Li C; Eydoux C; Contreras JM; Morice C; Quérat G; Gigante A; Pérez Pérez MJ; Jung ML; Canard B; Guillemot JC; Decroly E; Coutard B
    Antiviral Res; 2019 Mar; 163():59-69. PubMed ID: 30639438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an ELISA assay for screening inhibitors against divalent metal ion dependent alphavirus capping enzyme.
    Kaur R; Mudgal R; Narwal M; Tomar S
    Virus Res; 2018 Sep; 256():209-218. PubMed ID: 29958924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus.
    Wada Y; Orba Y; Sasaki M; Kobayashi S; Carr MJ; Nobori H; Sato A; Hall WW; Sawa H
    Virology; 2017 May; 505():102-112. PubMed ID: 28236746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of silymarin against chikungunya virus.
    Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
    Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations on VEEV nsP1 relate RNA capping efficiency to ribavirin susceptibility.
    Rabah N; Ortega Granda O; Quérat G; Canard B; Decroly E; Coutard B
    Antiviral Res; 2020 Oct; 182():104883. PubMed ID: 32750467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Chikungunya virus by an adenosine analog targeting the SAM-dependent nsP1 methyltransferase.
    Mudgal R; Mahajan S; Tomar S
    FEBS Lett; 2020 Feb; 594(4):678-694. PubMed ID: 31623018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Sensitive and Robust High-Throughput Screening Assay for Inhibitors of the Chikungunya Virus nsP1 Capping Enzyme.
    Bullard-Feibelman KM; Fuller BP; Geiss BJ
    PLoS One; 2016; 11(7):e0158923. PubMed ID: 27427769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
    Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
    Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitoylated Cysteines in Chikungunya Virus nsP1 Are Critical for Targeting to Cholesterol-Rich Plasma Membrane Microdomains with Functional Consequences for Viral Genome Replication.
    Bakhache W; Neyret A; Bernard E; Merits A; Briant L
    J Virol; 2020 May; 94(10):. PubMed ID: 32132240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a high-throughput antiviral assay for screening inhibitors of chikungunya virus and generation of drug-resistant mutations in cultured cells.
    Gong EY; Bonfanti JF; Ivens T; Van der Auwera M; Van Kerckhove B; Kraus G
    Methods Mol Biol; 2013; 1030():429-38. PubMed ID: 23821286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.